Blood-based screening test for early detection of gastric cancer using biomarker analysis. Designed for non-invasive risk stratification and identification of high-risk patients requiring endoscopic evaluation. Supports clinical decision-making in gastric cancer prevention and early diagnosis.
Manufactured by
HymonBio Co., Ltd.
Suzhou, Jiangsu, China
HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 36 patents and obtained 16 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the Double Innovation Plan of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.
© 2026 Suplivia · Home · Browse Products